Literature DB >> 20940109

Status of bacterial colonization, Toll-like receptor expression and nuclear factor-kappa B activation in normal and diseased human livers.

Rashmi Singh1, Jay Bullard, Mamta Kalra, Senait Assefa, Anil K Kaul, Krystal Vonfeldt, Stephen C Strom, Robert S Conrad, Harvey L Sharp, Rashmi Kaul.   

Abstract

Epidemiological data on bacterial translocation (BT), colonization and inflammation in normal human livers is lacking. In this study we investigated the status of bacterial colonization and inflammation in the normal, cirrhotic primary biliary cirrhosis (PBC), and nonalcoholic steatohepatitis (NASH) human liver tissues. Comparatively normal livers showed increased bacterial colonization than PBC and NASH. We analyzed mRNA levels of Toll-like receptors (TLR) 2 and TLR4, and protein levels of TLR4. Phosphorylated IKKα (pIKKα) protein estimation served as a marker for nuclear factor-kappa B (NF-κB) activation. In spite of the increased bacterial colonization in normal liver tissues, lower levels of TLR2/4 mRNA and TLR4 and pIKKα proteins were found compared to PBC and NASH indicating the maintenance of suppressed inflammation and immune tolerance in normal livers. To our knowledge, this is the first clinical evidence showing suppressed inflammation despite bacterial colonization in normal human livers thus maintaining liver immune homeostasis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940109     DOI: 10.1016/j.clim.2010.09.006

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  18 in total

1.  Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.

Authors:  Diptadip Dattaroy; Ratanesh Kumar Seth; Suvarthi Das; Firas Alhasson; Varun Chandrashekaran; Gregory Michelotti; Daping Fan; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-12-30       Impact factor: 4.052

2.  Hepatic TLR4 signaling in obese NAFLD.

Authors:  Torfay Sharifnia; Joseph Antoun; Thomas G C Verriere; Giovanni Suarez; Julia Wattacheril; Keith T Wilson; Richard M Peek; Naji N Abumrad; Charles R Flynn
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-25       Impact factor: 4.052

Review 3.  Microbial translocation across the GI tract.

Authors:  Jason M Brenchley; Daniel C Douek
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

4.  The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis.

Authors:  Nazarena E Ferreyra Solari; María Eugenia Inzaugarat; Placida Baz; Elena De Matteo; Carol Lezama; Marcela Galoppo; Cristina Galoppo; Alejandra C Cherñavsky
Journal:  J Clin Immunol       Date:  2012-01-07       Impact factor: 8.317

Review 5.  Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis.

Authors:  Yaron Ilan
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 6.  Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?

Authors:  Gábor Firneisz
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

7.  Curcumin inhibits TLR2/4-NF-κB signaling pathway and attenuates brain damage in permanent focal cerebral ischemia in rats.

Authors:  Xian-kun Tu; Wei-zhong Yang; Jian-ping Chen; Yan Chen; Long-qiang Ouyang; Yi-chao Xu; Song-sheng Shi
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 8.  Clinical science workshop: targeting the gut-liver-brain axis.

Authors:  Vishal C Patel; Helen White; Sidsel Støy; Jasmohan S Bajaj; Debbie L Shawcross
Journal:  Metab Brain Dis       Date:  2015-10-08       Impact factor: 3.584

9.  Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers.

Authors:  Masashi Ninomiya; Yasuteru Kondo; Ryo Funayama; Takeshi Nagashima; Takayuki Kogure; Eiji Kakazu; Osamu Kimura; Yoshiyuki Ueno; Keiko Nakayama; Tooru Shimosegawa
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

Review 10.  The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease.

Authors:  María Teresa Arias-Loste; Emilio Fábrega; Marcos López-Hoyos; Javier Crespo
Journal:  Biomed Res Int       Date:  2015-09-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.